Drugs / silver citrate complex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03250923 | Sep 2024 | oral candidiasis | CelaCare Technologies, Inc. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | silver citrate complex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03250923 ↗ |
| Modality | Other / unclassified | “a silver citrate complex salt (0.01mg/ml)” NCT03250923 ↗ |
| Route | Oral | “Oral rinse solution” NCT03250923 ↗ |